Salient Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-70,781
| Closed | -$5.01M | – | 106 |
|
|
2017
Q2 | $5.01M | Buy |
70,781
+3,456
| +5% | +$245K | 0.1% | 71 |
|
|
2017
Q1 | $4.57M | Buy |
67,325
+23,955
| +55% | +$1.63M | 0.08% | 75 |
|
|
2016
Q4 | $3.11M | Buy |
43,370
+3,507
| +9% | +$251K | 0.06% | 86 |
|
|
2016
Q3 | $3.15M | Buy |
39,863
+2,152
| +6% | +$170K | 0.06% | 82 |
|
|
2016
Q2 | $3.15M | Buy |
37,711
+4,220
| +13% | +$352K | 0.07% | 85 |
|
|
2016
Q1 | $3.08M | Buy |
+33,491
| New | +$3.08M | 0.09% | 82 |
|